Last updated 32 days ago

A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152)

650 patients around the world
Available in Puerto Rico, Spain, Brazil, United States
Hoffmann-La Roche
5Research sites
650Patients around the world
This study is for people with
Liver Cancer
Hepatocellular Carcinoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital de Amor Amazônia
Recruiting
BR-364, 15 - Porto Velho, RO, Brazil
Irmandade da Santa Casa de Misericórdia de Porto Alegre
Recruiting
Rua Professor Annes Dias - Centro Histórico, Porto Alegre - RS, 90020-090, Brazil
INSCER - Instituto do Cérebro da PUC-RS
Recruiting
Av. Ipiranga, 6690, 4o Andar, Centro de Pesquisa Clínica do HSLPUCRS - Jardim Botânico – Porto Alegre/RS - 90610-000
Hospital de Câncer de Barretos - Fundação PIO XII
Recruiting
Rua Antenor Duarte Villela 1331 - Barretos, Sao Paulo, 14784-400
PanOncology Trials
Recruiting
Hospital Oncológico Dr. Isaac González Martínez, 150 Av. Centro Médico, San Juan, 00935, Puerto Rico
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy